SavedAdd your journal

Journals / Journal of Clinical and Analytical Medicine / 2013 / Cilt: 4 - Sayı: 5

Testis koruyucu cerrahi sonuçları

Outcomes of testis sparing surgery

Muhammet Fuat ÖZCAN
Bahri GÖK
Ziya AKBULUT
Muhammed Ersagun ARSLAN
Ali Fuat ATMACA
Serkan ALTINOVA
Pages
360–362
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion: Testis sparing surgery is a treatment option in selected cases with the davantages of fertility preservation and avoiding the need for long-term hormone replacement therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Our aim was to review the indications and results of partial orchidectomy.
📊
Key Findings & Data:Material and Method: We retrospectively investigated pathologic and demographic features of patients who underwent partial orchidectomy between February 2005 and December 2011.
💡
Conclusion & Impact:Discussion: Testis sparing surgery is a treatment option in selected cases with the davantages of fertility preservation and avoiding the need for long-term hormone replacement therapy.
🔬Design:Review & Systematic Survey
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Our aim was to review the indications and results of partial orchidectomy. Material and Method: We retrospectively investigated pathologic and demographic features of patients who underwent partial orchidectomy between February 2005 and December 2011. Results: Partial orchidectomy was performed on 7 patients aged between 2 and 30 years. Partial orchidectomy was performed for testicular tumour/mass on solitary testis, bilateral testicular tumour, trauma on 3,2,1 patients respectively. Pathologic examination of the patient who was undergone partial orchiectomy for testicular trauma revealed a mixed germ cell tumour that was detected incidentally. Discussion: Testis sparing surgery is a treatment option in selected cases with the davantages of fertility preservation and avoiding the need for long-term hormone replacement therapy.

Özet

Amaç: Parsiyel orşiektomi endikasyonları ve sonuçlarının gözden geçirilmesi amaçlanmıştır. Gereç ve Yöntem: Şubat 2005 –Aralık 2011 tarihleri arasında parsiyel orşiektomi yapılan hastaların demografik ve patolojik özellikleri retrospektif olarak incelendi. Bulgular: Yaşları 2 ile 30 arasında değişen 7 hastaya parsiyel orşiektomi yapıldı. Parsiyel orşiektomi endikasyonları: 3 hastada soliter testiste kitle, 2 hastada bilateral testiküler kitle, 1 hastada ise travma idi. Travma nedeniyle parsiyel orşiektomi yapılan hastada insidental olarak miks germ hücreli tümör saptandı. Tartışma: Fertilitenin korunması, uzun dönemde hormon replasman tedavisi gereksinimini ortadan kaldırabilmesi ile testis koruyucu cerrahi seçilmiş vakalarda tercih edilebilecek tedavi seçeneğidir.

🔖

Cite This Article

ÖZCAN, M. F., GÖK, B., AKBULUT, Z., ARSLAN, M. E., ATMACA, A. F., ALTINOVA, S. (2022). Testis koruyucu cerrahi sonuçları. Journal of Clinical and Analytical Medicine, Cilt: 4 - Sayı: 5, 360–362. https://ajindex.com/articles/561290

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group. (EGCCCG): part I. Eur Urol. 2008;53(3):478-96
  2. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. EAU guidelines on testicular cancer: 2011 update. Eur Urol. 2011;60(2):304-19
  3. Che M, Tamboli P, Ro JY, Park DS, Ro JS, Amato RJ, et al: Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center. Cancer 2002;95(6):1228-33
  4. Dieckmann KP, Boeckmann W, Brosig W, Jonas D, Bauer HW. Bilateral testicular germ cell tumors. Report of nine cases and review of the literature. Cancer 1986;57(6):1254-8
  5. Fordham MV, Mason MD, Blackmore C, Hendry WF, Horwich A. Management of the contralateral testis in patients with testicular germ cell cancer. Br J Urol 1990;65(3):290-3
  6. Carmignani L, Gadda F, Gazzano G, Nerva F, Mancini M, Ferruti M, et al. High incidence of benign testicular neoplasm diagnosed by ultrasound. J Urol 2003;170(5):1783-6
  7. Elert A, Olbert P, Hegele A, Barth P, Hofmann R, Heidenreich A. Accuracy of frozen section examination of testicular tumors of uncertain origin. Eur Urol 2002;41(3):290–3
  8. Heidenreich A, Weissbach L, Höltl W, Albers P, Kliesch S, Köhrmann KU, et al. German Testicular Cancer. Study Group. German Testicular Cancer Study Group. Organ sparing surgery for malignant germ cell tumor of the testis. J.Urol 2001;166(6):2161–5
  9. Chung PW, Jewett MA, Warde PR: Testicular radiation for primary seminoma in a solitary testis. Can J Urol 2006;13(1):2975-7
  10. Kratzik C, Schatzl G, Lackner J, Marberger M. Transcutaneous high-intensity focused ultrasonography can cure testicular cancer in solitary testis. Urology 2006;67(6):1269-73
  11. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. European Association of Urology. Eur Urol. 2011;60(2):304-19
  12. Lawrentschuk N, Zuniga A, Grabowksi AC, Rendon RA, Jewett MA. Partial orchiectomy for presumed malignancy in patients with a solitary testis due to a prior germ cell tumor: a large North American experience. J Urol. 2011;185(2):508-13
  13. Canda AE, Atmaca AF, Ozdemir AT, Akbulut Z, Balbay MD. Testis sparing surgery for sequential bilateral testicular tumors. Can J Urol. 2009;16(3):4677-81
  14. Dieckmann KP, Skakkebaek NE. Carcinoma in situ of the testis: review of bio-